Quantum Financial Partners
NVO icon

Quantum Financial Partners’s Novo Nordisk NVO Stock Holding History

Quantum Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5,315
Closed -$255K – 163
2026
Q2 		$255K Buy
+5,315
New +$228K 0.13% 125

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Folketrygdfondet
Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Quantum Financial Partners's NVO Position: Q3 2026 in Review

Quantum Financial Partners sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 5,315 shares — an estimated $255K sold.

Quantum Financial Partners first reported a position in NVO in Q2 2026 and held it in 1 quarter. The position peaked at $255K in Q2 2026. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Quantum Financial Partners reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • Quantum Financial Partners sold 5,315 Novo Nordisk shares in Q3 2026, an estimated $255K.
  • Quantum Financial Partners first reported a position in Novo Nordisk in Q2 2026 and held it in 1 quarter.
  • Quantum Financial Partners's Novo Nordisk position peaked at $255K in Q2 2026.
  • 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Quantum Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.